Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2019-09-09 2019-02-28
Drug Identification Number 02382636 02382636
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Common or Proper name Hydromorphone Hydromorphone
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10x1mL vial 10x1mL vial
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-09-01
Actual discontinuation date 2019-09-01
Remaining supply date 2019-09-01 2019-09-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments